For patients researching CJC-1295 for recovery, body composition, or age-related growth hormone support, Tesamorelin may be part of a safer conversation because it has a regulated medical pathway and provider monitoring
"Or we can decline to engage, cede the ground of the gray market, deny patient choice, and give up the chance to understand these compounds well enough to use them safely and to advance our understanding of human health along the way." In recent years, peptides like BPC-157, KPV, TB-500, MOTS-C, emideltide, epitalon and Semax have been produced in a legal gray area
The numbers are worth sitting with
Baker, Suzanne M
References Novo Nordisk presents phase 3 data for next-generation amylin cagrilintide, leading to advancement into dedicated clinical Programme, 16 September 2025, Novo Nordisk, DAscanio AM, Mullally JA, Frishman WH